Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240124518
Ladenburg Thalmann analyst Aydin Huseynov maintains Aileron Therapeutics (NASDAQ:ALRN) with a Buy and raises the price targe...
Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(1.54) per share versus losses of $(1.00) per share from the s...
- SEC Filing
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:ALRN), a biopharmaceutical company advancing a novel pipeline of first-i...
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-e...
